Sitemap Fiscal year Key performance indicators Letter to the shareholders ZEISS Expert Talk 2025 The Supervisory Board Report of the Supervisory Board Share Summary management report Carl Zeiss Meditec Group Business report Underlying conditions Overall assertion on the financial position Results of operations Financial position Net assets Orders on hand Events of particular significance Non-financial performance indicators Sustainability Employees Compliance Production Research and development Brands and patents Financial statements of Carl Zeiss Meditec AG Preparation of the financial statements Summary of business development Income statement according to HGB Results of operations Balance sheet Net assets and financial position Employees Appropriation of profits Declaration on corporate governance and corporate governance report Opportunity and risk report Risk management Major opportunities Significant risks Disclosures pursuant to Section 289a and 315a HGB Outlook Final declaration of the Management Board on the dependent company report Declaration on corporate governance and corporate governance report Remuneration report Remuneration of the Management Board Remuneration of the Supervisory Board Auditor’s Report Consolidated financial statements Consolidated income statement Consolidated statement of comprehensive income Consolidated statement of financial position Consolidated statement of changes in equity Consolidated statement of cash flows Notes General principles, accounting and valuation principles 1 General principles 2 Accounting and valuation policies 3 Reporting entity 4 Summarized financial information of material subsidiaries with non-controlling interests Notes to the consolidated income statement 5 Revenue 6 Other operating result 7 Personnel expenses 8 Financial result 9 Income taxes 10 Earnings per share Notes to the consolidated statement of financial position 11 Goodwill 12 Other intangible assets 13 Property, plant and equipment 14 At-equity investments 15 Inventories 16 Other financial assets 17 Other non-financial assets 18 Cash and cash equivalents 19 Assets held for sale 20 Equity 21 Provisions for pensions and similar obligations 22 Other provisions 23 Financial liabilities 24 Accrued liabilities 25 Other non-financial liabilities 26 Financial instruments and risk management Other disclosures 27 Notes to the statement of cash flows 28 Leases 29 Segment reporting 30 Government grants 31 Related party disclosures 32 Notifiable transactions in the reporting period 33 Additional disclosures on capital management 34 Events after the end of the reporting period 35 Other mandatory disclosures pursuant to Section 315e HGB 36 Clearance for publication Responsibility statement Independent Auditor’s Report
